Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | AIDX 20/20 Biolabs, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $0.47 -1.1% | $15.06 -2.0% |
| StockIQ Score | 45D+ Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 14F | 13F |
| Fundamental | 35F | 35F |
| Growth | 71B | 50C- |
| Fair Value | 50C- | 38F |
| News | 86A | 50C- |
| Quality | 58C | 50C- |
| Risk | 34F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
AIDX outperforms AAPG in growth (71 vs. 50) and technicals (53 vs. 18), making it stronger in those areas. Both share the same fundamental score (35), but AIDX’s overall investor rating is moderate while AAPG is weak. AAPG slightly leads in valuation (38 vs. 50), though AIDX’s valuation is still average.